(Lectures and Speeches) The 118th Annual Meeting of the Japan Pediatric Society (April, 17 (Fri.))
date : 4/17/2015
In
the session entitled ‘Japan’s initiative for early access of pediatric
pharmaceuticals’. Dr. Miyata Toshio, an Executive Director of HGPI,
presented the recent trends in Europe and the United States and the most
important issues of pediatric drug development.
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022）
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
![[Registration Open] Online Seminar “Implementing Chronic Kidney Disease (CKD) Measures into Society: Towards a Data-Driven Health System” (April 21, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260421_CKDonlineseminar-.png)
